Dr Lal PathLabs Ltd hits a fresh 52-week high
Dr Lal PathLabs Ltd hits a fresh 52-week high

Dr Lal PathLabs Ltd hits a fresh 52-week high

DSIJ Intelligence Article rating: 4.2

During Wednesday’s trading session, the stock of Dr Lal PathLabs registered a new 52-week high. The stock jumped more than 16.82 per cent and touched a fresh 52-week high of Rs 2,329.80 on BSE.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 3.0

The market opened in green on October 7, 2020, overall volumes in futures & options currently stand at 3,35,95,099 contracts with a turnover of Rs. 23,42,833.63 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

DSIJ Intelligence Article rating: 5.0

The market opened in green on October 7, 2020, overall volumes in futures & options currently stand at 3,35,95,099 contracts with a turnover of Rs. 23,42,833.63 crore.

Is it a good time to revisit your financial plan?
Is it a good time to revisit your financial plan?

Is it a good time to revisit your financial plan?

DSIJ Intelligence Article rating: 5.0

Once you have made your elaborate financial plan, you might get complacent and presume that all the hard work has been done. Good fortune is what happens when opportunity meets with planning.

Glenmark Pharma gets USFDA nod for multiple sclerosis drugs
Glenmark Pharma gets USFDA nod for multiple sclerosis drugs

Glenmark Pharma gets USFDA nod for multiple sclerosis drugs

DSIJ Intelligence Article rating: 4.3

Glenmark Pharmaceuticals informed the exchanges on Wednesday that it has been granted final approval by United States Food & Drug Administration (USFDA) for Dimethyl Fumarate delayed-release capsules, 120 mg and 240 mg, the generic version of Tecfidera delayed-release capsules, 120 mg and 240 mg, of Biogen, Inc.

This small-cap stock gains by more than 30 per cent in just two days
This small-cap stock gains by more than 30 per cent in just two days

This small-cap stock gains by more than 30 per cent in just two days

DSIJ Intelligence Article rating: 4.1

The shares of Thyrocare Technologies have gained by almost 31.45 per cent in just two trading sessions. The stock has been buzzing since the second day of this week when it jumped by 14.10 per cent during Tuesday’s trading session.

RSS
First27272728272927302732273427352736Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR